Literature DB >> 27152492

Prevalence and determinants of chronic kidney disease in the Swiss population.

Valentina Forni Ogna1, Adam Ogna2, Belen Ponte3, Luca Gabutti2, Isabelle Binet4, David Conen5, Paul Erne6, Augusto Gallino7, Idris Guessous8, Daniel Hayoz9, Franco Muggli10, Fred Paccaud11, Antoinette Péchère-Bertschi12, Paolo M Suter13, Murielle Bochud11, Michel Burnier1.   

Abstract

QUESTIONS UNDER STUDY: The prevalence of chronic kidney disease (CKD) is increasing worldwide, corresponding to an increased risk of cardiovascular disease. The latest study on prevalence of CKD involving the three linguistic regions of Switzerland dates back to 2002-2003 and definitions have changed since then. We aimed to assess the current prevalence and determinants of CKD in the Swiss general population.
METHODS: We analysed the data of 1353 participants from a cross-sectional population-based survey performed in 2010-2012 in the three linguistic regions of Switzerland. The prevalence of CKD and the derived cardiovascular risk categories were assessed according to the Kidney Disease - Improving Global Outcomes (KDIGO) 2012 classification, using estimated glomerular filtration rate (GFR; CKD-Epidemiological Collaboration equation) and albuminuria level. Multivariate logistic regression was used to analyse factors associated with CKD.
RESULTS: We included 660 men and 693 women, equally distributed in four age categories (15-29, 30-44, 45-59 and over 60 years). The overall prevalence of CKD was 10.4%. The prevalence in the low, moderate, high and very high risk KDIGO categories were 89.6%, 8.4%, 1.6% and 0.5%, respectively. The prevalence of CKD was similar in all linguistic regions. In multivariate analysis, female gender, older age, diabetes and uric acid were independently associated with CKD in persons ≥45 y. In younger participants, diabetes and lower educational level were associated with CKD.
CONCLUSIONS: In the general Swiss population, CKD affects one in ten adults. Subjects older than 60 years, as well as patients with diabetes and hypertension, show a high prevalence of CKD. Systematic screening may be recommended in this population.

Entities:  

Mesh:

Year:  2016        PMID: 27152492     DOI: 10.4414/smw.2016.14313

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  5 in total

1.  A survey of non-communicable diseases and their risk factors among university employees: a single institutional study.

Authors:  Emmanuel I Agaba; Maxwell O Akanbi; Patricia A Agaba; Amaka N Ocheke; Zumnan M Gimba; Steve Daniyam; Edith N Okeke
Journal:  Cardiovasc J Afr       Date:  2017-08-15       Impact factor: 1.167

2.  Associations of Waist Circumference, Socioeconomic, Environmental, and Behavioral Factors with Chronic Kidney Disease in Normal Weight, Overweight, and Obese People.

Authors:  Tuyen Van Duong; Pei-Yu Wu; Evelyn Yang; Yuh-Feng Lin; Hung-Yi Chiou; Shwu-Huey Yang
Journal:  Int J Environ Res Public Health       Date:  2019-12-13       Impact factor: 3.390

Review 3.  How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice.

Authors:  Erietta Polychronopoulou; Gregoire Wuerzner; Michel Burnier
Journal:  Vasc Health Risk Manag       Date:  2021-01-06

4.  Decomposition of outpatient health care spending by disease - a novel approach using insurance claims data.

Authors:  Michael Stucki; Janina Nemitz; Maria Trottmann; Simon Wieser
Journal:  BMC Health Serv Res       Date:  2021-11-22       Impact factor: 2.655

Review 5.  Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis.

Authors:  Yangyang Zhang; Xiaoyu Zhu; Xiu Huang; Xuejiao Wei; Dan Zhao; Lili Jiang; Xiaoxia Zhao; Yujun Du
Journal:  Front Med (Lausanne)       Date:  2020-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.